Bladder cancer trials in Bulgaria
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in BulgariaA Phase 3 Open-Label, Randomized Controlled Trial of T-bren (BL-M07D1) vs. Platinum-based Chemotherapy in Patients with HER2-expressing metastatic urothelial cancer with disease progression on or after anti-PD-(L)1-based therapy
- Where
- Burgas, Sofia, Sofiya
- Age
- 18 years and over
- People
- 203 worldwide
- Run by
- Systimmune Inc.
See details and how to join2026-527617-29-00 · EU 2026-527617-29-00 - Phase 2Taking peoplePhase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
- Where
- Plovdiv, Sofia, Sofiya
- Age
- 18 years and over
- People
- 285 worldwide
- Run by
- Tyra Biosciences, Inc
See details and how to joinNCT07265947 · EU 2025-523539-20-00 - Phase 4Taking peopleA Rollover Study to Follow the Long-term Durability of Response to UGN-103 in Participants With Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer (LG-IR-NMIBC) From Study BL013
- Where
- Gabrovo, Shumen, Sofiya
- Age
- 18 years and over
- People
- 33 worldwide
- Run by
- Urogen Pharma Ltd.
See details and how to join2026-526359-75-00 · EU 2026-526359-75-00 - Phase 3Taking peopleRoll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Sofia
- Age
- 18 years and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532 · EU 2023-507337-22-00 - Phase 3Taking peopleA Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Where
- Haskovo, Plovdiv, Shumen, Sofia
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- UroGen Pharma Ltd.
See details and how to joinNCT06774131 · EU 2024-519343-15-00